Interventions for residual dizziness after successful repositioning maneuvers in patients with benign paroxysmal positional vertigo

The effects of vestibular exercise, medication,or no-treatment, on resolving residual dizziness after successful repositioning maneuvers in patients with benign paroxysmal positional

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017328

Enrollment

Unknown

Registered

2018-07-24

Start date

2018-08-01

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign paroxysmal positional vertigo

Interventions

Group A:Vestibular rehabilitation (VR) for 4 weeks

Group B:Betahistine for 4 weeks

Group C:no treatment

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as unilateral BPPV (unilateral posterior semicircular canal BPPV or horizontal semicircular canal BPPV) according to the clinical practice guideline issued by American Academy of Otolaryngology and head and neck surgery (AAO-HNSF) in 2017; 2. Aged 18~80 years; 3. Reporting residual symptoms after successful repositioning maneuvers.

Exclusion criteria

Exclusion criteria: 1. Anterior semicircular canal BPPV or multicanal BPPV; 2. Recurrent BPPV within 6 months; 3. Subjects with coexisting vestibular disorders, including Meniere disease, vestibular neuritis, labyrinthitis, and peripheral vestibular loss; 4. Subjects with severe cervical spine disease; 5. Subjects with severe cardiovascular diseases; 6. Subjects with known cerebral vascular disease like carotid stenosis; 7. Cognitive impairment; 8. Pregnant or breast-feeding; 9. Had taken vestibulosupressant, antihistamines, and ototoxic medications in the past 3 months.

Design outcomes

Primary

Measure	Time frame
vestibular activities and participation;computerized dynamic posturography;VAS;	—

Secondary

Measure	Time frame
duration of unsteadiness;quality of life;VEMPs (including oVEMP and cVEMP);psychological status;	—

Countries

China

Contacts

Public ContactLi Huawei

Eye & ENT Hospital of Fudan University

hwli@shmu.edu.cn+86 13918696618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026